GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioLASCO Taiwan Co Ltd (ROCO:6662) » Definitions » Research & Development

BioLASCO Taiwan Co (ROCO:6662) Research & Development : NT$0.0 Mil (TTM As of Sep. 2024)


View and export this data going back to 2018. Start your Free Trial

What is BioLASCO Taiwan Co Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. BioLASCO Taiwan Co's Research & Development for the three months ended in Sep. 2024 was NT$0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Sep. 2024 was NT$0.0 Mil.

BioLASCO Taiwan Co Research & Development Historical Data

The historical data trend for BioLASCO Taiwan Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioLASCO Taiwan Co Research & Development Chart

BioLASCO Taiwan Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

BioLASCO Taiwan Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

BioLASCO Taiwan Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioLASCO Taiwan Co  (ROCO:6662) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

BioLASCO Taiwan Co Research & Development Related Terms

Thank you for viewing the detailed overview of BioLASCO Taiwan Co's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

BioLASCO Taiwan Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioLASCO Taiwan Co Ltd (ROCO:6662) » Definitions » Research & Development
Comparable Companies
ROCO:4131 ROCO:6864 ROCO:3118 ROCO:6917 ROCO:6814 ROCO:6549 ROCO:6808 ROCO:4732 ROCO:6236 ROCO:6652 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
N/A
Address
3rd Floor, 316 Chong-yang Road, Taipei, TWN, 115
Website
http://www.biolasco.com.tw
BioLASCO Taiwan Co Ltd is a biological experimental development company. The company has produced strains of laboratory rats and mice, including outbreed stocks, inbreed strains, and immunedeficient models. It offers reagent kit and equipment which include Allentown, Biomedical data system, PLAS LABS.

BioLASCO Taiwan Co Headlines

No Headlines